Occupy Everything: An Interview With Velcrow Ripper

Occupy Everything: An Interview with Velcrow Ripper

Filed under: drug addiction treatment act 2000

I just looked back at an early treatment for the "Fierce Love" trilogy which was originally called the "Scared Sacred" trilogy. I'd just … So, what's happened since the Arab Spring and the European Summer and the Occupy Movement is a revitalization …
Read more on Cannabis Culture


Join EverSmoke by Voicing Your Opinion on Section 918 of Tobacco Act

Filed under: drug addiction treatment act 2000

The Family Smoking Prevention and Tobacco Control Act (Tobacco Act) was structured to regulate cigarettes, smokeless tobacco, and “roll your own” under a newly created Center for Tobacco Products (CTP) and to continue regulation of so-called “Nicotine …
Read more on SBWire (press release)


US FDA announces first Breakthrough Therapy Designations

Filed under: drug addiction treatment act 2000

… for potential additional indications beyond the drug's currently-approved use in CP patients aged six and over who have the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene; there are estimated to be around 2 …
Read more on PharmaTimes


Making the Case for Adjuncts

Filed under: drug addiction treatment act 2000

"But, of course, it became a lure or a drug that they couldn't wean themselves from. …. “If parents did understand the issue, I think they would certainly support better treatment of adjunct faculty and they would endorse the hiring of more full-time …
Read more on Inside Higher Ed



LSD Human Experimentation / Research Documentary Film – Experimental Compound MER 17 (Frenquel) and LSD-25: Psychosis. National Security Council. Central Intelligence Agency. (09/18/1947 – 12/04/1981). ARC Identifier 1634172 / Local Identifier 263.1057. This film examines human medical experiments to determine the efficacy of LSD-25 and MER 17 (Frenquel) on treating psychosis. Producer: National Archives and Records Administration. Creative Commons license: Public Domain Chemist Albert Hofmann, working at the Sandoz Corporation pharmaceutical laboratory in Switzerland, first synthesized LSD in 1938. He was conducting research on possible medical applications of various lysergic acid compounds derived from ergot, a fungus that develops on rye grass. Searching for compounds with therapeutic value, Hofmann created more than two dozen ergot-derived synthetic molecules. LSD is sold on the street in tablets, capsules, and occasionally in liquid form. It is an odorless and colorless substance with a slightly bitter taste that is usually ingested orally. It is often added to absorbent paper, such as blotter paper, and divided into small decorated squares, with each square representing one dose. CONTROL STATUS LSD is a Schedule I substance under the Controlled Substances Act. Schedule I drugs, which include heroin and MDMA, have a high potential for abuse and serve no legitimate medical purpose. Its two precursors lysergic acid and lysergic acid amide are both in Schedule III of the CSA. The LSD precursors ergotamine and ergonovine are